Nakamura T, Maruyama K, Ohnuki T, Hattori K, Watanabe K, Nagatomo T
Department of Pharmacology, Niigata College of Pharmacy, Niigata, Japan.
Pharmacology. 1999 Nov;59(5):234-8. doi: 10.1159/000028325.
This study was performed to assess the affinity of tamsulosin to the alpha(1L)- in addition to alpha(1B)-adrenoceptor (alpha(1)-AR) subtypes coexisting in the canine aorta using the radioligand binding assay. The antagonistic effects of this drug on contraction of the rat aorta were also assessed, and the results were compared with those obtained with prazosin, amosulalol, labetalol, ketanserin, clonidine and propranolol. The pKi value of tamsulosin to the alpha(1L)-subtype was lower than those of prazosin and HV-723, but higher than those of amosulalol, ketanserin and labetalol. The pKi value of tamsulosin for the alpha(1B)-subtype in the canine aorta was similar to that of prazosin. However, this drug showed a higher pKi value than amosulalol, HV-723, labetalol and ketanserin. On the other hand, the order of inhibition potencies for contraction of the rat aorta by phenylephrine was as follows: prazosin > tamsulosin > amosulalol > HV-723 > labetalol > ketanserin > clonidine > propranolol. Thus, although the affinity of tamsulosin to the alpha(1B)-AR subtype in the canine aorta was as high as that in the bovine prostate reported in our previous study, the affinity (pKi 7. 87) of this drug to alpha(1L)-AR in the canine aorta was lower than that (pKi 8.99) in the bovine prostate. These observations suggested that the pharmacological potencies of tamsulosin in the aorta and prostate may be different.
本研究旨在采用放射性配体结合试验评估坦索罗辛对犬主动脉中共存的α(1L)-以及α(1B)-肾上腺素能受体(α(1)-AR)亚型的亲和力。还评估了该药物对大鼠主动脉收缩的拮抗作用,并将结果与哌唑嗪、阿唑洛尔、拉贝洛尔、酮色林、可乐定和普萘洛尔的结果进行比较。坦索罗辛对α(1L)-亚型的pKi值低于哌唑嗪和HV-723,但高于阿唑洛尔、酮色林和拉贝洛尔。坦索罗辛对犬主动脉中α(1B)-亚型的pKi值与哌唑嗪相似。然而,该药物的pKi值高于阿唑洛尔、HV-723、拉贝洛尔和酮色林。另一方面,去氧肾上腺素对大鼠主动脉收缩的抑制效力顺序如下:哌唑嗪>坦索罗辛>阿唑洛尔>HV-723>拉贝洛尔>酮色林>可乐定>普萘洛尔。因此,尽管坦索罗辛对犬主动脉中α(1B)-AR亚型的亲和力与我们先前研究报道的牛前列腺中的亲和力一样高,但该药物对犬主动脉中α(1L)-AR的亲和力(pKi 7.87)低于牛前列腺中的亲和力(pKi 8.99)。这些观察结果表明,坦索罗辛在主动脉和前列腺中的药理效力可能不同。